293 related articles for article (PubMed ID: 19917940)
1. Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases.
Cardinal J; de Vera ME; Marsh JW; Steel JL; Geller DA; Fontes P; Nalesnik M; Gamblin TC
Arch Surg; 2009 Nov; 144(11):1035-9. PubMed ID: 19917940
[TBL] [Abstract][Full Text] [Related]
2. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
Lerut JP; Orlando G; Adam R; Schiavo M; Klempnauer J; Mirza D; Boleslawski E; Burroughs A; Sellés CF; Jaeck D; Pfitzmann R; Salizzoni M; Söderdahl G; Steininger R; Wettergren A; Mazzaferro V; Le Treut YP; Karam V;
Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
[TBL] [Abstract][Full Text] [Related]
3. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
4. Getting a handle on managing rare tumors.
Hebert JC
Arch Surg; 2009 Nov; 144(11):1039. PubMed ID: 19928296
[No Abstract] [Full Text] [Related]
5. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
[TBL] [Abstract][Full Text] [Related]
6. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
[TBL] [Abstract][Full Text] [Related]
7. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
8. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
9. Does histology predict outcome for malignant vascular tumors of the liver?
Groeschl RT; Miura JT; Oshima K; Gamblin TC; Turaga KK
J Surg Oncol; 2014 Apr; 109(5):483-6. PubMed ID: 24284733
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management.
Emamaullee JA; Edgar R; Toso C; Thiesen A; Bain V; Bigam D; Kneteman N; Shapiro AM
Liver Transpl; 2010 Feb; 16(2):191-7. PubMed ID: 20104492
[TBL] [Abstract][Full Text] [Related]
11. Hepatic epithelioid hemangioendothelioma: long-term results of surgical management.
Mosoia L; Mabrut JY; Adham M; Boillot O; Ducerf C; Partensky C; Baulieux J
J Surg Oncol; 2008 Nov; 98(6):432-7. PubMed ID: 18792957
[TBL] [Abstract][Full Text] [Related]
12. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Pinter M; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Stauber R; Grünberger B; Müller C; Kölblinger C; Peck-Radosavljevic M; Sieghart W
Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359
[TBL] [Abstract][Full Text] [Related]
13. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?
Kim JM; Kwon CH; Joh JW; Kim SJ; Shin M; Kim EY; Moon JI; Jung GO; Choi GS; Lee SK
Transplant Proc; 2010 Apr; 42(3):821-4. PubMed ID: 20430181
[TBL] [Abstract][Full Text] [Related]
14. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
15. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.
Luo J; Peng ZW; Guo RP; Zhang YQ; Li JQ; Chen MS; Shi M
Radiology; 2011 Apr; 259(1):286-95. PubMed ID: 21330557
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma].
Li CX; Zhang Y; Gao L
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):942-5. PubMed ID: 17533749
[TBL] [Abstract][Full Text] [Related]
17. [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].
Zhang Z; Wu M; Liu Q
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):214-6. PubMed ID: 11776840
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Features and Prognosis of Hepatic Epithelioid Hemangioendothelioma After Liver Resection and Transplantation.
Jung DH; Hwang S; Hong SM; Kim KH; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu E; Lee SG
Ann Transplant; 2016 Dec; 21():784-790. PubMed ID: 28031549
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases.
Hur S; Chung JW; Kim HC; Oh DY; Lee SH; Bang YJ; Kim WH
J Vasc Interv Radiol; 2013 Jul; 24(7):947-56; quiz 957. PubMed ID: 23602421
[TBL] [Abstract][Full Text] [Related]
20. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
